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Abstract 
We are developing a set of ontologies that deal with 
vector-borne diseases and the arthropod vectors that 
transmit them. For practical reasons (application 
priorities), we initiated this project with an ontology 
of insecticide resistance followed by a series of 
ontologies that describe malaria as well as 
physiological processes of mosquitoes that are 
relevant to, and involved in, disease transmission. 
These will be expanded to encompass other vector-
borne diseases as well as non-mosquito vectors. The 
aim of the whole undertaking, which is worked out in 
the frame of the international IDO (Infectious 
Disease Ontology) project, is to provide the 
community with a set of ontological tools that can be 
used both in the development of specific databases 
and, most importantly, in the construction of decision 
support systems to control these diseases. 
The problem of vector-borne diseases  
Epidemiologists have brought together in one 
“functional “group a series of diseases of different 
etiology and pathogenesis that share one key 
component: their mode of transmission (see Goddard, 
19991 and several chapters of Marquardt, 20052 for 
specific questions addressing insect-borne diseases 
and their vectors). These diseases are transmitted by 
the bite of a specific arthropod vector, which is 
usually an insect. The pathogenic agent is passed 
with the saliva transferred during the bite to the 
potential patient. Two additional characteristics are 
shared by most vector-borne diseases, namely most 
people affected live in the tropical regions of the 
world and, connected to this, the diseases affect 
mostly populations that are also heavily affected by 
poverty. The pathogens responsible for these diseases 
are very diverse, ranging from protozoan parasites 
(e.g. Plasmodium spp. in malaria, Leishmania spp. in 
leishmaniosis) and bacteria (e.g. Borrelia spp. in 
Lyme disease) to worms (e.g. Nematodes in filariasis 
and river blindness) to viruses (e.g. Dengue, Yellow 
fever). Similarly, the vectors range from mosquitoes 
(e.g. malaria and Dengue) and flies (e.g. Tsetse in 
African trypanosomiasis) to kissing bugs (Chagas’ 
disease) and ticks (e.g. Lyme disease). The extreme 
variation in the biology of both pathogens and the 
vectors makes it difficult to address vector-borne 
diseases as a whole. Importantly, these difficulties 
also affect important aspects such as prevention, 
epidemiology, therapy, etc. 
A common theme, which in a sense unites these 
diseases, is the fact that their transmission can be 
blocked if the agents that transmit them, i.e. the 
arthropod vectors, are removed from the pertinent 
chain of events3. Vector control has therefore 
historically become a conditio sine qua non for the 
control of these infections4,5, and this fact has been 
exemplified by the elimination of malaria from most 
non-tropical areas of the globe6. While leading to 
about half a billion cases in the tropics every year, 
and still being responsible for anything between one 
and three million deaths (mostly children in sub-
Saharan Africa), this killer illness has practically 
disappeared from Europe and North America through 
intense insecticidal measures aimed at eliminating the 
Anopheles vectors. It should be stressed that, with the 
exception of the Yellow fever7, no vaccine is 
currently available for any vector-borne disease as an 
alternative prevention strategy that would act on a 
different level than that of the actual vector. 
Prevention focused on the vector includes not only 
control of insect populations through environmental 
management or the use of chemicals, but also the 
protection of individuals through the use of clothing, 
repellents, nets and screens8. 
Although greatly successful in the previous century, 
insect-control programmes are now immensely 
obstructed by a variety of reasons. These range from 
community opposition to a vast usage of chemicals9, 
to the development of resistance against these very 
chemicals by the insect vectors to be controlled10. 
Moreover, these problems are aggravated by several 
facts: resistance against drugs is also encountered in 
the pathogens11; vaccine development, if at all 
possible, is slow12; new drug development is not only 
slow but extremely expensive and the areas affected 
by the diseases in question are certainly not the ones 
that can easily spearhead such efforts due to the lack 
of economic and scientific resources in these areas13. 
It is therefore of utmost importance to develop 
  
innovative strategies for the control of vector-borne 
diseases. One novel approach is to use IT 
technologies as a complement to the application of 
developments in the biology of disease vectors. 
While the latter projects make use of scientific 
research products such as whole genome 
sequences14,15, transgenesis16, and the use of other 
“intelligent” approaches17 the former potentially 
brings new specific tools that can be used for a more 
efficient, and often close-to-the-field management of 
pertinent disease data, especially entomological ones.  
In this context, our group has embarked on a long 
project that involves the development of ontologies 
dealing with disease vectors and vector-born 
diseases18,19. The obvious rationale behind is the need 
of these ontologies to unify the “language” spoken by 
vector biologists and epidemiologists. The ultimate 
end is to build a comprehensive ontology for insect-
borne diseases that may consist of sub-ontologies, 
each addressing a specific aspect of the whole. In the 
frame of the Infectious Disease Ontology project 
(http://www.infectiousdiseaseontology.org/Home.ht
ml), we initiated this effort focusing on malaria, but 
we are already expanding this to encompass the other 
diseases of this class as well. These ontologies, some 
of which are already available and some under 
construction, will be presented below in a summary 
form. 
Ontologies and vector-borne diseases: a brief 
description 
The aspects of vector-borne diseases that are in need 
of an ontological  description range from those that 
deal with the diseases as such (e.g. pathogenesis, 
clinical aspects, therapy, etc.), to vector biology 
(physiological processes of the vectors) and to 
epidemiology and control in the widest sense of the 
terms (prevention, insect control, etc.). As stated 
earlier, these aspects are extremely diverse and 
complex, simply given the multitude of organisms 
involved (vectors and pathogens in addition to the 
human host) and the fact that we are often dealing 
with populations (additional level of granularity!). 
The construction of a comprehensive ontology, thus, 
if at all feasible, must be addressed using a piecemeal 
approach. It is clear that certain fundamental 
decisions have to be taken at the initial phases, and an 
open-ended advance is, in our mind, a must. In that 
sense, we decided, early on, that the end product 
would have to follow i) the rules set by the OBO 
Foundry20 and ii) be based on the basic formal 
ontology21,22. If long-term interoperability of future 
databases is to be achieved, these two choices are a 
prerequisite. This rule, of course, is the end goal and 
we decided to keep a certain degree of flexibility 
throughout the project until a “unified” ontology is 
constucted. One example for such a flexible approach 
is the fact that the ontology of insecticide resistance 
in mosquitoes that we developed (MIRO) does not 
follow the BFO in its initial versions but, rather is 
structured such that it can be adopted without many 
problems by the community that immediately needs 
to apply it in the field (Topalis et al., 2009, 
submitted). The MIRO forms the core of the related 
database on insecticide resistance (IRbase) that we 
also developed, and which was adopted for 
immediate use by the World Health Organization 
(Topalis et al., 2009, submitted). We should state that 
we are nevertheless in the process of long term 
restructuring the ontology along BFO standards, such 
that its contents can be later included in the 
comprehensive ontology on vector-borne diseases.  
Although already submitted to and listed by the OBO 
Foundry (http://www.obofoundry.org/cgi-
bin/detail.cgi?id=mosquito_insecticide_resistance ), 
MIRO is a pure application ontology that is being 
used to drive a dedicated database, IRbase 
(http://anobase.vectorbase.org/ir/ ). It consists of four 
specially devised sub-ontologies that cover all 
aspects of inscticide resistance, with an emphasis on 
field work and monitoring. Thus, although 
mechanisms of resistance are covered, this is not 
done in detail. Furthermore, MIRO’s fifth 
component, a geographical one, uses in toto the 
controlled vocabulary Gazeteer (http://darwin.nerc-
oxford.ac.uk/gc_wiki/index.php/GAZ_Project) to 
provide IRbase curators with records describing the 
areas in which data were collected. The MIRO is 
constantly being updated upon request by members 
of the international community that is involved in the 
study of insecticide resistance. 
The second ontology, which is still nameless, covers 
physiological processes of mosquitoes that are 
involved in disease transmission. The processes 
covered do not only address the actual transmission, 
i.e. the interplay between vectors and pathogens but, 
importantly, also the actual progression of events in 
the vector. We want to stress that the processes 
mentioned here are, in their vast majority, processes 
on the level of the organism and not cellular or sub-
cellular ones, such as the ones covered by the GO23, 24 
. Thus, (near) top level classes are, among others, 
behaviour, sensory perception, processes of the 
immune system and nutrition. As an example, when 
looking at the children of “behaviour”, one will find a 
line of terms leading, through the adult feeding 
behaviour to entities such as the four phases of 
“interrupted feeding” (exploratory phase, imbibing 
phase, probing phase and withdrawal phase). The 
ontology also covers processes that are not directly 
  
“linked” to disease transmission and this, obviously, 
for reasons of completion. For reasons of 
orthogonality, in all cases in which terms are already 
covered by established ontologies, we adhere to 
these, along with their descendants. This is notably 
the case for the Processes sub-ontology of the GO. 
Our ontology is far from complete, although it 
already covers more than 600 terms, which are all 
fully defined. 
The next ontology that we are in the process of 
populating with terms is the one describing malaria. 
This is the actual ontology that we decided to develop 
in the frame of IDO, and which we plan to expand in 
the near future in order to cover other vector-borne 
diseases as well. It is built based on BFO and the 
IDO reference ontology 
(http://www.infectiousdiseaseontology.org/IDO_files
/IDO_10.08.07.obo.txt ), and it is meant to cover 
malaria on all possible levels. These obviously 
include both the clinical aspects of the disease in the 
widest sense (i.e. including epidemiology, etc.) and 
the biology of the disease that describes processes 
and objects of not immediate clinical relevance. We 
consider as such items like proteins involved in the 
penetration of both mosquito and human/vertebrate 
cells as well as their interacting partners in the 
Plasmodium parasites. Again, similarly to the case of 
the ontology of physiological processes, we have 
taken care to include wherever possible direct 
imports of pre-existing ontologies. One such example 
is the Plasmodium parasite life cycle stage and its 
descendants that all have crossreferences to the, at the 
moment, inactive Plasmodium life cycle ontology. 
The malaria ontology has at this time about 600 
terms. 
Ontologies and vector-borne diseases: concluding 
remarks 
The ontologies that we are constructing can be 
described as pure application ontologies that are 
meant to form the basis for specific tools such as 
specific databases or decision support systems for 
various diseases. The need for such tools became 
apparent immediately after the first working version 
of the MIRO and its “cousin” IRbase were made 
public. Not only did the international community 
immediately decide to adopt both tools, but already 
within a few months after the initiation of data 
population, there are about 800 sampled populations 
that are shown in the database. This is about 683 
more than what the insecticide resistance section in 
VectorBase carried, the only repository for data of 
this kind. In addition to databases that are driven by 
ontologies in an increasing fashion (see for example 
databases using the ontology-depending schema 
Chado25, such as FlyBase26,27 and VectorBase28,29, 
ontologies are ideal tools for the design of intelligent 
decision support systems. In cases such as vector-
borne diseases, whose control is also hampered by 
weak infrastructure in endemic countries, these DSSs 
can be used by medical workers and health agencies 
in remote areas, either for ongoing studies or in cases 
that need immediate attention30, 31 .  
One of the intricacies that we are already faced with 
is the planned expansion of the malaria-oriented 
ontologies, to cover many other vector-borne 
diseases. To understand the magnitude of the 
problem one should think of the fact that vector-
borne diseases represent major threats to public 
health in wide and ecologically diverse areas of the 
world, are caused by completely different pathogens 
and are transmitted by completely different vectors.  
Thus, the challenge now is how to cover this broad 
spectrum of facts in a single ontology. There is 
naturally the possibility of cutting through the 
Gordian knot, by devising separate ontologies for 
each disease. The counter-argument in this case 
would be that, brought to an extreme, each malaria 
form (i.e. tertian, malignant and benign, and quartan, 
should have its own ontology) similar to the different 
forms of filariasis that are caused by different species 
of nematodes and whose clinical aspect differ only 
slightly. In addition, similarities between these 
diseases and the agents that transmit them may be 
obscured if different ontologies were used and this 
would certainly have a negative impact on their value 
in the long term. Therefore, we are still trying to 
solve the knot in a non-Alexandrian way. By 
“merging” the ontologies into one, we can also 
actively support the rules of the OBO Foundry and 
provide an example of how the construction of a 
large and comprehensive ontology can, later on, 
provide advantages to its users.  
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